Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-30
SponsorUniversity of California, San Diego

About this trial

Young people at clinical high risk for psychosis are more likely to experience suicide thoughts than the general population, but there are few suicide prevention programs designed specifically for them. This study will develop and evaluate a recovery-oriented suicide prevention group program for young people at clinical high risk for psychosis.

The program will be led by a clinician and a peer with lived experience. It will help participants identify reasons for living, build hope, set meaningful recovery goals, strengthen social connections, and learn strategies to better remember and use suicide prevention strategies developed during the program. Caregivers will also be invited to participate in a session to learn ways to support their young person.

The study will first gather feedback from participants, caregivers, clinicians, and community advisors to refine the program. Researchers will then compare the program plus standard care with standard care alone to determine whether it improves personal recovery and increases participants' ability to remember and use suicide prevention strategies. Researchers will also collect feedback from participants and program staff to better understand how the program can be integrated into early psychosis services.

Eligibility criteria

Qualifiers

symptoms of clinical high risk for psychosis in the last two years

lifetime active suicide ideation and/or lifetime suicide behavior

has a caregiver willing to participate

not able to read and write in English

Disqualifiers

employed at the University of California, San Diego or University of California, Los Angeles early psychosis program

Trial design

Treatments tested in this trial

  • Suicide Prevention Intervention
  • Standard Care (in control arm)

Treatment groups

108 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Diego

Lead sponsor

University of California, Los Angeles

Collaborator

National Institute of Mental Health (NIMH)

Collaborator